Summary Autoimmune thyroid diseases are characterized by intrathyroidal infiltration of CD4+ and CD8 + T lymphocytes reactive to self-thyroid antigens. Early studies analysing T cell receptor (TCR) Va gene usage have shown oligoclonal expansion of intrathyroidal T lymphocytes but not peripheral blood T cells. However, TCR Vb diversity of the isolated CD4 + and CD8 + T cell compartments in the peripheral blood has not been characterized fully in these patients. We performed complementarity-determining region 3 (CDR3) spectratyping as well as flow cytometric analysis for the TCR Vb repertoire in peripheral CD4+ and CD8 + T cells from 13 patients with Graves' disease and 17 patients with Hashimoto's thyroiditis. Polyclonal TCR Vb repertoire was demonstrated by flow cytometry in both diseases. In contrast, CDR3 spectratyping showed significantly higher skewing of TCR Vb in peripheral CD8 + T cells but not CD4+ T cells among patients with Hashimoto's thyroiditis compared with healthy adults. We found trends towards a more skewed CDR3 size distribution in those patients having disease longer than 5 years and requiring thyroid hormone replacement. Patients with Graves' disease exhibited no skewing both in CD4 + and CD8 + T cells. These findings indicate that clonal expansion of CD8 + T cells in Hashimoto's thyroiditis can be detected in peripheral blood and may support the role of CD8+ T cells in cell-mediated autoimmune attacks on the thyroid gland in Hashimoto's thyroiditis.
IntroductionOmenn syndrome (OS) is a peculiar immunodeficiency characterized by erythroderma, lymphadenopathy, hepatosplenomegaly, eosinophilia, hypogammaglobulinemia, elevated serum IgE, and activated/oligoclonal T cells. 1,2 The genes responsible for OS include RAG1, RAG2, Artemis, RMRP, and IL7RA. [3][4][5][6][7][8] Clinical manifestations resembling OS were demonstrated in cases of severe combined immunodeficiency (SCID) with maternal T-cell engraftment and of atypical DiGeorge syndrome. 9,10 In addition, we have recently reported an X-linked SCID (XSCID) patient with massive skin infiltration of natural killer (NK) cells, resulting in OS-like manifestations. 11 Here, we describe another case of XSCID mimicking OS. The patient carried a splice site mutation that allowed development of peripheral T and NK cells, and showed revertant T-cell mosaicism caused by a second-site mutation predominately in the skin. Both of these findings may have contributed to his phenotypic variation of XSCID. Methods PatientA 5-month-old Japanese boy from nonconsanguineous parents was hospitalized because of failure to thrive, protracted diarrhea, and hypoproteinemia. He developed generalized erythematous rash and alopecia at 1 month of age ( Figure 1A,B), followed by persistent cough, fever, hepatosplenomegaly, and lymphadenopathy. Laboratory studies revealed leukocytosis (60.0 ϫ 10 9 /L) with eosinophilia, liver dysfunction, and a low level of serum immunoglobulin G (IgG; 0.17 g/L). Serum IgE levels were significantly elevated at 1300 kIU/L. Immunophenotypic analysis of lymphocytes showed an increased percentage of CD3 ϩ T cells (93.1%), the majority expressing the activation markers CD45RO and HLA-DR. The ratio of CD4 ϩ to CD8 ϩ T cells was 1.1. The patient's CD20 ϩ B and CD56 ϩ NK cells were detectable at 3.8% and 3.2%, restrictively. The level of soluble interleukin-2 receptor was markedly elevated at 10 895 kIU/L. He had a normal thymus shadow. A skin biopsy exhibited massive lymphocytic infiltration and mild spongiosis ( Figure 1C,D). His maternal half-brother died of interstitial pneumonia at infancy. Cellular and molecular studiesCell isolation, fluorescence-activated cell sorting (FACS) analysis for the common gamma chain (␥c) and T-cell receptor (TCR) repertoire, spectratyping, microsatellite analysis, and mutation analysis of ␥c were performed as described elsewhere. [11][12][13][14][15] The purity of the sorted CD4 ϩ T, CD8 ϩ T, CD19 ϩ B, and CD56 ϩ NK cells was 98.1%, 99.3%, 86.4%, and 98.3%, respectively. T-cell and B-cell lines from the patient were established by transformation with Herpes virus saimiri and Epstein-Barr virus, respectively. Approval for the study was obtained from the Human Research Committee of Kanazawa University Graduate School of Medical Science, and informed consent was obtained in accordance with the Declaration of Helsinki. Results and discussionThe patient's clinical findings were reminiscent of OS. However, he showed neither mutation in the RAG genes (data not shown) nor severely restric...
Background/Aims: In oxidative stress, heme oxygenase-1 (HO-1) plays a pivotal role in maintaining renal function and protecting renal structure, especially in renal tubular epithelial cells. We examined urinary HO-1 (uHO-1) levels to assess whether uHO-1 acts as a sensitive biomarker for detecting tubulointerstitial inflammatory damage in renal diseases. Methods: Immunohistochemical analyses and enzyme-linked immunosorbent assays for uHO-1 were performed using 61 urine samples (supernatants and sediment lysates) from healthy children and renal disease patients. Results: Proximal and distal epithelial cells showed higher uHO-1 levels than squamous and urothelial cells. Inflammatory renal disease patients had higher uHO-1 levels than noninflammatory renal disease patients and controls. In IgA nephropathy, patients with interstitial cellular infiltration showed higher uHO-1 levels than those without it. Among patients with increased urinary β2-microglobulin or N-acetyl-β-D-glucosaminidase levels, uHO-1 levels increased only in those with renal disease and tubulointerstitial inflammatory damage. uHO-1 levels positively correlated with urinary interleukin-6 in inflammatory renal disease patients. Conclusions: These results indicate that uHO-1 is a potentially useful, novel, and noninvasive biomarker for evaluating the degree of tubulointerstitial inflammatory damage in renal disease.
A B Figure. A, Microscopic examination confirmed giant cell transformation of hepatocytes (hematoxylin and eosin staining). B, Café-au-lait spots following the Blaschko line on her neck and anterior chest.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.